FDA OKs Orencia for Juvenile Arthritis

Courtesy WebMD Health  Thu, 04/10/2008 - 00:00

The FDA has approved Orencia as a treatment for moderate to severe juvenile rheumatoid arthritis (JRA).

Sponsors

 

Related items

Hope for arthritis vaccine 'cure'
A single injection of modified cells could halt the advance of rheumatoid arthritis, say UK scientists.

New athritis drug gets approval recommendation
WASHINGTON -- A government advisory panel Tuesday recommended approval of the drug Actemra, promoted as a new type of treatment for rheumatoid...

Enbrel May Help Treat Alzheimer's
A drug commonly used to treat rheumatoid arthritis and other immune-based conditions may also be effective at targeting language-related Alzheimer's...

Drug Combo Fights Rheumatoid Arthritis
In the early stages of rheumatoid arthritis, taking the drugs Enbrel and methotrexate may make remission more likely than taking methotrexate alone,...

Heavy birthweight increases risk of developing rheumatoid arthri...
(Hospital for Special Surgery) People who have a birthweight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com